Are
Pesticides Causing Parkinson's Disease?
By
Robin Marantz Henig, OnEarth Magazine
Posted on June 19, 2009, Printed on June 24, 2009
http://www.alternet.org/story/140673/
versión
portugués
This
story originally appeared in OnEarth Magazine.
Jackie
Christensen was 32 when her body began to betray her. She had just returned
to work after the birth of her second son and when she tried to type,
two fingers on her left hand refused to cooperate. "They wouldn't
go where I would want them to on the keyboard," says Christensen,
who at the time -- it was 1997 -- was co-director of the food and health
program at the Institute for Agriculture and Trade Policy, a Minneapolis
think tank. "I also had what they frequently call frozen shoulder,
with a very low range of motion in my left arm."
The
first neurologist Christensen went to responded flippantly to her suggestion
that she might have multiple sclerosis, which she had self-diagnosed
because of her relatively young age and the fact that she was female.
"If you want me to write that down, I will," she remembers
him saying, refusing to pursue the matter further. A second neurologist
thought it was all in Christensen's mind and referred her to a psychiatrist.
Over the next several months, her symptoms got progressively worse,
and she finally consulted neurologist number three. His startling diagnosis:
Parkinson's disease.
"I
thought, 'I can't have Parkinson's because I'm not old,'" Christensen
recalls. But a trial of the standard treatment, a drug called L-dopa,
seemed to work. Based on that clinical observation, the diagnosis was
confirmed. This was in 1998, when Christensen was not quite 35, and
she has been on L-dopa, with varying degrees of success, ever since.
Why
did a disease that usually affects people in their sixties and seventies,
and that affects men more often than women, strike this vibrant young
mother? Christensen, a lifelong environmental activist, suspected an
environmental cause -- not only because she was politically inclined
to, but because she knew that accumulating scientific information was
pointing in that direction. In the past few years, Christensen has been
part of a movement exploring a possible connection between exposure
to environmental toxins -- in particular, the organophosphate pesticides
-- and Parkinson's disease, through her work with the Collaborative
on Health and the Environment, a national network of advocacy and scientific
organizations. She is co-founder of CHE's working group on Parkinson's
Disease and the Environment.
A
cause-and-effect relationship between environmental neurotoxins and
Parkinson's is difficult to prove. As with many other scientific efforts
to establish disease causation through population studies, there will
probably never be a smoking gun that settles things once and for all.
Population studies can detect associations between certain suspected
agents and diseases such as cancer, but it's hard to draw conclusions
about what causes a disease from studies that can register only correlations.
In the case of Parkinson's and the environment, however, there has been
a steadily mounting consensus about such a connection, and the pace
has quickened in the past year or so.
A
January 2009 consensus statement from CHE, in collaboration with the
Parkinson's Action Network, a patient advocacy group, found that there
was "limited suggestive evidence of an association" between
pesticides and Parkinson's, and between farming or agricultural work
and Parkinson's. This followed by just a few months the publication
of Environmental Threats to Healthy Aging, a report co-authored by the
Science and Environmental Health Network, a consortium of advocacy groups
based in Ames, Iowa; it included a summary of 31 population studies
that have looked at the possible connection between pesticide exposure
and Parkinson's. Twenty-four of those studies, according to the report,
found a positive association, and in 12 cases the association was statistically
significant. In some studies, the group found, there was as much as
a sevenfold greater risk of Parkinson's in people exposed to pesticides.
In addition, in April 2009, scientists at the University of California,
Los Angeles (UCLA), published a provocative study connecting the disease
not only to occupational pesticide exposure but also to living in homes
or going to schools that were close to a pesticide-treated field.
Taken
together, 30-plus years of research add up to an increasingly persuasive
conclusion: exposure to pesticides and other toxins increases the risk
of Parkinson's disease, and we are only now beginning to wrestle with
the true scope of the damage.
Parkinson's
is the second most common neurodegenerative disease (after Alzheimer's)
in the United States, affecting between 1 million and 1.5 million Americans.
The majority of cases occur in people over 65, about 60 percent of them
male. It leads to uncontrollable tremors, muscle rigidity, and the inability
to direct your arms or legs to move when you want them to. People with
Parkinson's often have a masklike, impassive expression. They may have
difficulty speaking clearly and develop a characteristic shuffling gait.
Cognitive skills usually are not affected, though some functions like
memory and decision-making can be impaired, and, in the face of the
gradual and inevitable encroachment of physical limitations, people
with Parkinson's often become depressed.
In
part because it can take many forms, Parkinson's disease is difficult
to diagnose. Several movement disorders have been classified in the
general category known as Parkinson's-like syndrome, or parkinsonism.
Scientists are divided about whether Parkinson's disease and parkinsonism
are even related in any meaningful way, beyond sharing some symptoms.
The two conditions may not even involve the same brain defects. The
strict definition of Parkinson's disease is a loss of cells in the substantia
nigra, a small structure in the basal ganglia region of the midbrain
(though other brain structures are now thought to be involved as well).
The substantia nigra ordinarily secretes the neurotransmitter dopamine,
which is involved in many of the brain's functions, including the control
of motor activity.
Often
a diagnosis of Parkinson's disease is made the way it was made for Christensen:
by a trial run of L-dopa, which boosts dopamine in the brain. If it
works, the problem must be Parkinson's. It's a circular kind of logic,
but it's all that most doctors have. There still are no definitive blood
tests or brain scans to make the diagnosis.
In
trying to establish risk factors for Parkinson's, one of the first decisions
investigators must make is which cases to include in their epidemiological
studies. Some studies include all patients, those with parkinsonian
syndrome as well as those with definitively diagnosed Parkinson's. Some
researchers limit their study subjects to people with Parkinson's disease
and a demonstrated reduction of dopamine.
One
of the more restrictive studies is a small subset of the massive Agricultural
Health Study (AHS), which began in 1993 and involves nearly 90,000 individuals
licensed to apply pesticides to crops, as well as their families. The
AHS, conducted by the National Cancer Institute and the National Institute
for Environmental Health Sciences with funding from the Environmental
Protection Agency and the National Institute of Occupational Safety
and Health, has tracked these workers to determine their risk of developing
cancer and other serious diseases.
In
2002, scientists decided to look at a segment of this large database
to assess the environmental risks for Parkinson's. This study-within-a-study,
with the catchy acronym FAME (Farming and Movement Evaluation), compared
the pesticide exposure of 114 AHS participants who have Parkinson's
disease, as diagnosed by two specialists from the team, with exposure
among 384 control cases matched for age, sex, and state of residence
(either Iowa or North Carolina, where all the subjects are from). A
group of scientists led by Caroline Tanner of the Parkinson's Institute
of Sunnyvale, California, and Freya Kamel of the National Institute
of Environmental Health Sciences looked at five possible risk factors
in these 498 individuals: pesticide exposure; exposure to other neurotoxins;
lifestyle factors such as diet, smoking, and caffeine use; the amount
of melanin, or pigment, in the skin; and specific genetic variations,
particularly those in genes involved in the production of dopamine or
the metabolism of xenobiotics -- non-natural chemicals such as drugs
and toxins that are transported and detoxified through pathways that
scientists already understand.
The
FAME study, the results of which are being prepared for publication
next year, found that pesticide exposure was a significant risk factor
for Parkinson's disease. The parent AHS study found that people who
had been exposed to pesticides sporadically over a lifetime were 1.2
times more likely to develop Parkinson's than those who had not been.
And when the exposure was heavy -- the kind of lifetime exposure seen
in career pesticide applicators, or a single massive exposure as the
result of a spill -- that increased risk jumped to 2.3 times. The riskiest
pesticides were found to be some of those most commonly used in American
agriculture, among them Paraquat and Trifluralin, both herbicides used
to kill broadleaf weeds in food crops. (Paraquat is now restricted to
commercially licensed users in the United States because of its toxicity,
but it remains the second most widely used herbicide in the world, applied
to more than 50 crops in 120 countries.)
These
results were part of a cascade of findings pointing to a connection
between environmental toxins, especially pesticides, and Parkinson's
disease. As long ago as the 1970s, epidemiologists noticed that Parkinson's
was more likely to occur in people who had grown up in rural areas,
especially those who had lived on farms. But they were not sure which
aspect of a rural background was relevant. Living near livestock? Drinking
well water? Being exposed to pesticides? "It's been very difficult
to pin down an explanation," Kamel says.
Pesticides
seemed the most likely culprit. "Animal models have shown that
specific pesticides can cause parkinsonian changes," Kamel says,
"and we have mechanistic data also" -- that is, evidence of
biological processes at the level of the interaction between brain cells
and the chemicals in common pesticides -- that can explain how a cause-and-effect
relationship might work. "To the degree we understand the neurological
mechanisms that may be related to Parkinson's disease," Kamel says,
"it seems that certain specific pesticides might play a role."
"Despite
remaining uncertainties and data gaps," wrote the authors of the
2008 report by the Science and Environmental Health Network -- Jill
Stein, Ted Schettler, Ben Rohrer, and Maria Valenti -- "the body
of evidence linking pesticide exposure to Parkinson's disease fulfills
generally accepted criteria for establishing causation." When combined
with "extensive laboratory animal data" specifying the underlying
biology of this relationship, they wrote, "collectively, this evidence
supports the conclusion that pesticide exposures can cause Parkinson's
disease in some people."
Like
most other population studies, this one has no way of proving that,
for any one individual, X definitely led to Y -- that Jackie Christensen's
early-onset Parkinson's disease, for instance, was caused by her exposure
to pesticides as a teenager. To Christensen, however, the causal connection
is clear. Growing up in rural Minnesota, she spent summers working on
local farms. In her early teens, this meant engaging in a practice known
as "walking beans." A pickup truck would drop off a bunch
of youngsters, including Christensen, at one end of a field, and they
would walk the rows of soybeans, weeding as they went. Later, Christensen
and her friends rode a "bean buggy," a rig attached to the
front of a tractor from which they would spray the herbicide Roundup,
sometimes dyed purple so they could see where it was landing, carefully
aiming for the weeds and trying to avoid the beans. Often she was dressed
in nothing more than a bathing suit and a baseball cap. "I had
a great tan those summers," she wrote in the introduction to her
book, The First Year: Parkinson's Disease; An Essential Guide for the
Newly Diagnosed, "and I had no idea nor gave any thought whatsoever
to what I might be exposing myself to, or what the effects might be.
After the first day or two of spraying, I could no longer smell the
odor of the herbicide. I do remember that when I would come home, my
mother would immediately tell me to take a shower because I smelled
like chemicals."
As
a young adult, Christensen had a single massive chemical exposure, during
a political demonstration that involved wading into the Mississippi
River in St. Louis. Wastewater treatment runoff made the water as neon
green as Mountain Dew. She says it's "anybody's guess" what
was in the water, but since many of the industries in
St. Louis at the time discharged their wastes into the river, she says
the brew probably included organophosphate pesticides, dry cleaning
solvents, and other compounds. "After that action, within an hour
I had a headache," she says, "and I was nauseated and felt
fatigued and lousy for a week. I know now that those are common symptoms
of acute pesticide poisoning. At the time I didn't think about what
was causing it. I was 25 and thought I was bulletproof."
Since
the British physician James Parkinson first described the "shaking
palsy" in 1817, Parkinson's disease has been linked to a variety
of possible environmental causes, both natural and artificial. It has
been linked, too, to genetic factors, dating back to the beginning of
the twentieth century, when early-onset Parkinson's was first found
to run in a few scattered, unlucky families. Those who study the connection
between Parkinson's and the environment suggest that it's probably the
combined result of having a genetic predisposition to the disease and
a dangerous exposure to some sort of neurotoxin. A favorite expression
of people in this field is that "genetics loads the gun and environment
pulls the trigger."
In
the 1950s, scientists noticed that a large proportion of the Chamorro
people, who live on the Pacific island of Guam, were gripped by a syndrome
that rendered them stiff and immobile by middle age. It looked a lot
like Parkinson's disease. What made the situation so fascinating (and
so perplexing) was that in some patients the symptoms were closer to
two other neurodegenerative diseases -- Alzheimer's and amyotrophic
lateral sclerosis (Lou Gehrig's disease). After decades of research,
scientists discovered that the culprit was a local dietary staple: a
rodent known as a fruit bat. The bat drank nectar from the cycad tree,
from which it received a concentrated dose of a brain toxin, the amino
acid beta-methylamino-L-alanine (BMAA). When people ate the meat of
the fruit bat, they ingested huge amounts of BMAA. The story was told
in 2002, when the journal Neurology published an article about the fruit
bats and their "biomagnification" of BMAA. The findings are
still the subject of some debate, but they were consistent with the
accumulating picture: that at least some environmental agents might
account for at least some forms of parkinsonism.
In
1982, six young people showed up in emergency rooms in northern California
unable to move, speak, or eat on their own. This time the detective
work was accomplished much more rapidly. It took only a few weeks for
William Langston, then a neurologist at the Santa Clara Valley Medical
Center in San Jose, to put the story together. The patients were all
heroin users, and they had all used a batch of garage-concocted heroin
that was contaminated with the chemical compound 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine,
or MPTP. "At the molecular level, very little separated a toxic
chemical from a harmless one," Langston and John Palfreman wrote
in their book, The Case of the Frozen Addicts. But that small chemical
change was enough to turn the designer heroin into one of the most potent
known neurotoxins, virtually wiping out all the cells of the substantia
nigra, which produces dopamine. MPTP has a molecular structure very
much like the herbicide Paraquat. So the "frozen addicts"
were taken as further evidence that both pesticide exposure and MPTP
could be related to the same kind of dramatic brain damage.
The
tragedy of the addicts (who recovered some function with L-dopa treatments)
had a silver lining. MPTP turned out to be an excellent way to create
parkinsonian symptoms in experimental animals -- a necessary first step
in the search for a cure.
Scientists
also observed these symptoms in groups of people exposed to unrelated
compounds, such as heavy metals. One in particular, manganese, was implicated
in a 2006 study of residents of the steelmaking town of Hamilton, Ontario,
who had a higher-than-expected rate of Parkinson's disease. Investigators
attributed this to the manganese content of particulate air pollution
from factory emissions. It turns out that manganese is an ingredient
in the widely used fungicide Maneb.
But
pesticides remain the clearest culprit. One study found that in the
brains of people who had died of Parkinson's disease, the substantia
nigra had higher levels of Dieldrin (an organochlorine pesticide no
longer approved for use in the United States) and of lindane (an insecticide
occasionally still used to treat scabies and lice) than did the brains
of people who had died of other causes. Laboratory studies have also
provided important clues to the connection between pesticides and brain
damage. When human brain cells are grown in culture and exposed to a
variety of chemicals, several widely used pesticides -- in particular,
Paraquat and Rotenone, a natural pesticide approved for use in organic
foods -- have been shown to cause increased levels of alpha-synuclein,
a protein in the substantia nigra, similar to the levels that are seen
in people with Parkinson's disease.
Robin
Marantz Henig is a contributing writer to the New York Times Magazine.
She is the recipient of a 2009 Guggenheim Foundation fellowship, and
is the author of eight books on science, including The Monk in the Garden
(Houghton Mifflin), a finalist for the National Book Critics Circle
Award.
© 2009 OnEarth Magazine All rights reserved.
View this story online at: http://www.alternet.org/story/140673/